Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Neff

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Journal of Neurochemistry|August 1, 1991
Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouseM Hadjiconstantinou, J G Fitkin, A Dalia, et al.
Neurochemical Research|January 1, 1982
The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivityM Parenti, S Gentleman, M C Olianas, et al.
Neuroscience Letters|December 16, 1987
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) accelerates the accumulation of lipofuscin in mouse adrenal glandM Hadjiconstantinou, S Tjioe, H Alho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Pharmacological characterization of the muscarinic receptors mediating phosphoinositide hydrolysis in rat myometriumF G Varol, M Hadjiconstantinou, F P Zuspan, et al.
European Journal of Pharmacology|May 16, 1990
Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouseF B Weihmuller, J P Bruno, N H Neff, et al.
Brain Research|May 18, 1981
Regional differences in catecholamine formation and metabolism in the rat spinal cordF Karoum, J C Commissiong, N H Neff, et al.
Neurochemistry International|April 1, 1992
c-fos mRNA in mouse brain after MPTP treatmentA M Duchemin, K P Gudehithlu, N H Neff, et al.
Life Sciences|January 1, 1989
Gestational alterations in phospholipase C coupled muscarinic responseF G Varol, M Hadjiconstantinou, F P Zuspan, et al.
European Journal of Pharmacology|October 27, 1998
Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathwaysE A Young, A M Duchemin, N H Neff, et al.
Life Sciences|January 1, 1989
Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated miceF B Weihmuller, M Hadjiconstantinou, J P Bruno, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Journal of Neurochemistry|August 1, 1991
Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouseM Hadjiconstantinou, J G Fitkin, A Dalia, et al.
Neurochemical Research|January 1, 1982
The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivityM Parenti, S Gentleman, M C Olianas, et al.
Neuroscience Letters|December 16, 1987
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) accelerates the accumulation of lipofuscin in mouse adrenal glandM Hadjiconstantinou, S Tjioe, H Alho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Pharmacological characterization of the muscarinic receptors mediating phosphoinositide hydrolysis in rat myometriumF G Varol, M Hadjiconstantinou, F P Zuspan, et al.
European Journal of Pharmacology|May 16, 1990
Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouseF B Weihmuller, J P Bruno, N H Neff, et al.
Brain Research|May 18, 1981
Regional differences in catecholamine formation and metabolism in the rat spinal cordF Karoum, J C Commissiong, N H Neff, et al.
Neurochemistry International|April 1, 1992
c-fos mRNA in mouse brain after MPTP treatmentA M Duchemin, K P Gudehithlu, N H Neff, et al.
Life Sciences|January 1, 1989
Gestational alterations in phospholipase C coupled muscarinic responseF G Varol, M Hadjiconstantinou, F P Zuspan, et al.
European Journal of Pharmacology|October 27, 1998
Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathwaysE A Young, A M Duchemin, N H Neff, et al.
Life Sciences|January 1, 1989
Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated miceF B Weihmuller, M Hadjiconstantinou, J P Bruno, et al.
Pageof 21